Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions

Bedaquiline, pretomanid, and linezolid, with or without moxifloxacin, have revolutionized treatment for drug-resistant tuberculosis. In Ukraine, we observed an 86% success rate (394 of 460) under programmatic conditions when drugs were accessible, exceeding prior estimates (58%) and aligning with trial findings (80%-90%). However, access and implementation remain a concern in conflict-affected settings.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-04-24
DOI
https://doi.org/10.1093/cid/ciaf214
Citations
1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions

Olha Siomak, Vitaly Stephanovich Didyk, Tetiana Butova, Dmytro Butov et al.
1 citations
Clinical Infectious Diseases
Tuberculosis Research and Epidemiology
1.40
article

Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions

Olha Siomak, Vitaly Stephanovich Didyk, Tetiana Butova, Dmytro Butov, V.V. Hlynenko, Victor Næstholt Dahl, Vitalii Vekshyn, A.V. Fedorec, A. Ye. Bogomolov, О. М. Raznatovska, L. A. Hryshchuk, Iryna Makoida, S. І. Kornaha, Мykola Ostrovskyy, Mykhailo Kuzhko, Nataliia Chursina, Lyubov Markovtsiy, Vasyl Skryp, Ole Skouvig Pedersen, Y SHPAK, Natalia Kondratyuk, Tetiana Klymenko, Daria Yankovska, Daria Levandovska, Nataliia Yevsiukova
article en
1 citations

Abstract

Bedaquiline, pretomanid, and linezolid, with or without moxifloxacin, have revolutionized treatment for drug-resistant tuberculosis. In Ukraine, we observed an 86% success rate (394 of 460) under programmatic conditions when drugs were accessible, exceeding prior estimates (58%) and aligning with trial findings (80%-90%). However, access and implementation remain a concern in conflict-affected settings.

Clinical Infectious DiseasesVol. 81(4)
Ivano-Frankivsk National Medical University (UA), National University Zaporizhzhia Polytechnic (UA), Sumy State University (UA), Aarhus University Hospital (DK), Zaporizhzhia State Medical and Pharmaceutical University (UA), Lesya Ukrainka Volyn National University (UA), Polissia National University (UA), Consultative and Diagnostic Center (RU), Cherkasy State Technological University (UA), National Pirogov Memorial Medical University, Vinnytsya (UA), National Academy of Medical Sciences of Ukraine (UA), Saint-Petersburg Research Institute of Phthisiopulmonology (RU), I.Horbachevsky Ternopil National Medical University (UA), Kharkiv National Medical University (UA)
Good health and well-being
Openalex Percentile: Top 21%
Tuberculosis Research and Epidemiology
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.